{"id":4777,"date":"2026-09-05T17:02:13","date_gmt":"2026-09-05T14:02:13","guid":{"rendered":"https:\/\/wniss.com\/?p=4777"},"modified":"2026-09-05T17:03:10","modified_gmt":"2026-09-05T14:03:10","slug":"clinical-developments-in-new-antidepressant-drugs-options-to","status":"publish","type":"post","link":"https:\/\/wniss.com\/en-gb\/clinical-developments-in-new-antidepressant-drugs-options-to\/","title":{"rendered":"Clinical Developments in New Antidepressant Drugs Options To"},"content":{"rendered":"<figure class=\"wch-inserted-image\"><img decoding=\"async\" width=\"1024\" height=\"683\" src=\"https:\/\/wniss.com\/wp-content\/uploads\/2026\/09\/clinical-developments-in-new-antidepressant-drugs-options-to-1-9G5ZIY-1024x683.webp\" alt=\"Clinical Developments in New Antidepressant Drugs Options To - Clinical Developments in New Antidepressant\" loading=\"lazy\" class=\"wp-image-6218\" title=\"\" srcset=\"https:\/\/wniss.com\/wp-content\/uploads\/2026\/09\/clinical-developments-in-new-antidepressant-drugs-options-to-1-9G5ZIY-1024x683.webp 1024w, https:\/\/wniss.com\/wp-content\/uploads\/2026\/09\/clinical-developments-in-new-antidepressant-drugs-options-to-1-9G5ZIY-300x200.webp 300w, https:\/\/wniss.com\/wp-content\/uploads\/2026\/09\/clinical-developments-in-new-antidepressant-drugs-options-to-1-9G5ZIY-150x100.webp 150w, https:\/\/wniss.com\/wp-content\/uploads\/2026\/09\/clinical-developments-in-new-antidepressant-drugs-options-to-1-9G5ZIY-100x67.webp 100w, https:\/\/wniss.com\/wp-content\/uploads\/2026\/09\/clinical-developments-in-new-antidepressant-drugs-options-to-1-9G5ZIY-200x133.webp 200w, https:\/\/wniss.com\/wp-content\/uploads\/2026\/09\/clinical-developments-in-new-antidepressant-drugs-options-to-1-9G5ZIY-250x167.webp 250w, https:\/\/wniss.com\/wp-content\/uploads\/2026\/09\/clinical-developments-in-new-antidepressant-drugs-options-to-1-9G5ZIY-350x233.webp 350w, https:\/\/wniss.com\/wp-content\/uploads\/2026\/09\/clinical-developments-in-new-antidepressant-drugs-options-to-1-9G5ZIY-400x267.webp 400w, https:\/\/wniss.com\/wp-content\/uploads\/2026\/09\/clinical-developments-in-new-antidepressant-drugs-options-to-1-9G5ZIY-500x333.webp 500w, https:\/\/wniss.com\/wp-content\/uploads\/2026\/09\/clinical-developments-in-new-antidepressant-drugs-options-to-1-9G5ZIY-600x400.webp 600w, https:\/\/wniss.com\/wp-content\/uploads\/2026\/09\/clinical-developments-in-new-antidepressant-drugs-options-to-1-9G5ZIY.webp 1200w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<div class=\"markdown prose dark:prose-invert wrap-break-word w-full light markdown-new-styling\"><h2><span class=\"ez-toc-section\" id=\"Clinical_Developments_in_New_Antidepressant_Drugs_Emerging_Treatment_Options\"><\/span>Clinical Developments in New Antidepressant Drugs: Emerging Treatment Options<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Quick_Answer\"><\/span>Quick Answer<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>New antidepressant drugs are transforming depression treatment by targeting brain pathways beyond serotonin alone. Recent clinical developments include rapid-acting therapies, novel glutamate-based medications, neuroactive steroids, and investigational compounds designed to improve effectiveness, reduce side effects, and help people with treatment-resistant depression.<\/p><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_88 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/wniss.com\/en-gb\/clinical-developments-in-new-antidepressant-drugs-options-to\/#Clinical_Developments_in_New_Antidepressant_Drugs_Emerging_Treatment_Options\" >Clinical Developments in New Antidepressant Drugs: Emerging Treatment Options<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/wniss.com\/en-gb\/clinical-developments-in-new-antidepressant-drugs-options-to\/#Quick_Answer\" >Quick Answer<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/wniss.com\/en-gb\/clinical-developments-in-new-antidepressant-drugs-options-to\/#Why_New_Antidepressant_Drugs_Are_Needed\" >Why New Antidepressant Drugs Are Needed<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/wniss.com\/en-gb\/clinical-developments-in-new-antidepressant-drugs-options-to\/#How_Traditional_Antidepressants_Work\" >How Traditional Antidepressants Work<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/wniss.com\/en-gb\/clinical-developments-in-new-antidepressant-drugs-options-to\/#SSRIs\" >SSRIs<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/wniss.com\/en-gb\/clinical-developments-in-new-antidepressant-drugs-options-to\/#SNRIs\" >SNRIs<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/wniss.com\/en-gb\/clinical-developments-in-new-antidepressant-drugs-options-to\/#Atypical_Antidepressants\" >Atypical Antidepressants<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/wniss.com\/en-gb\/clinical-developments-in-new-antidepressant-drugs-options-to\/#The_Shift_Toward_Novel_Mechanisms\" >The Shift Toward Novel Mechanisms<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/wniss.com\/en-gb\/clinical-developments-in-new-antidepressant-drugs-options-to\/#Glutamate-Based_Antidepressants\" >Glutamate-Based Antidepressants<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/wniss.com\/en-gb\/clinical-developments-in-new-antidepressant-drugs-options-to\/#Esketamine_A_Rapid-Acting_Option\" >Esketamine: A Rapid-Acting Option<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/wniss.com\/en-gb\/clinical-developments-in-new-antidepressant-drugs-options-to\/#Neuroactive_Steroids\" >Neuroactive Steroids<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/wniss.com\/en-gb\/clinical-developments-in-new-antidepressant-drugs-options-to\/#Psychedelic-Assisted_Research\" >Psychedelic-Assisted Research<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/wniss.com\/en-gb\/clinical-developments-in-new-antidepressant-drugs-options-to\/#Triple_Reuptake_Inhibitors\" >Triple Reuptake Inhibitors<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/wniss.com\/en-gb\/clinical-developments-in-new-antidepressant-drugs-options-to\/#Personalized_Medicine\" >Personalized Medicine<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/wniss.com\/en-gb\/clinical-developments-in-new-antidepressant-drugs-options-to\/#Genetics\" >Genetics<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/wniss.com\/en-gb\/clinical-developments-in-new-antidepressant-drugs-options-to\/#Biomarkers\" >Biomarkers<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/wniss.com\/en-gb\/clinical-developments-in-new-antidepressant-drugs-options-to\/#Artificial_Intelligence_in_Drug_Discovery\" >Artificial Intelligence in Drug Discovery<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/wniss.com\/en-gb\/clinical-developments-in-new-antidepressant-drugs-options-to\/#Precision_Psychiatry\" >Precision Psychiatry<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/wniss.com\/en-gb\/clinical-developments-in-new-antidepressant-drugs-options-to\/#Faster_Symptom_Relief\" >Faster Symptom Relief<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/wniss.com\/en-gb\/clinical-developments-in-new-antidepressant-drugs-options-to\/#Addressing_Cognitive_Symptoms\" >Addressing Cognitive Symptoms<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/wniss.com\/en-gb\/clinical-developments-in-new-antidepressant-drugs-options-to\/#Improving_Emotional_Function\" >Improving Emotional Function<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/wniss.com\/en-gb\/clinical-developments-in-new-antidepressant-drugs-options-to\/#Reducing_Side_Effects\" >Reducing Side Effects<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/wniss.com\/en-gb\/clinical-developments-in-new-antidepressant-drugs-options-to\/#Safety_Considerations\" >Safety Considerations<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/wniss.com\/en-gb\/clinical-developments-in-new-antidepressant-drugs-options-to\/#Who_May_Benefit_Most\" >Who May Benefit Most?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/wniss.com\/en-gb\/clinical-developments-in-new-antidepressant-drugs-options-to\/#Ongoing_Clinical_Trials\" >Ongoing Clinical Trials<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-26\" href=\"https:\/\/wniss.com\/en-gb\/clinical-developments-in-new-antidepressant-drugs-options-to\/#Future_Directions\" >Future Directions<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-27\" href=\"https:\/\/wniss.com\/en-gb\/clinical-developments-in-new-antidepressant-drugs-options-to\/#Frequently_Asked_Questions\" >Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-28\" href=\"https:\/\/wniss.com\/en-gb\/clinical-developments-in-new-antidepressant-drugs-options-to\/#Are_new_antidepressant_drugs_better_than_older_medications\" >Are new antidepressant drugs better than older medications?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-29\" href=\"https:\/\/wniss.com\/en-gb\/clinical-developments-in-new-antidepressant-drugs-options-to\/#Which_new_antidepressant_works_the_fastest\" >Which new antidepressant works the fastest?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-30\" href=\"https:\/\/wniss.com\/en-gb\/clinical-developments-in-new-antidepressant-drugs-options-to\/#Are_these_medications_available_everywhere\" >Are these medications available everywhere?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-31\" href=\"https:\/\/wniss.com\/en-gb\/clinical-developments-in-new-antidepressant-drugs-options-to\/#Can_newer_antidepressants_replace_psychotherapy\" >Can newer antidepressants replace psychotherapy?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-32\" href=\"https:\/\/wniss.com\/en-gb\/clinical-developments-in-new-antidepressant-drugs-options-to\/#Are_investigational_antidepressants_safe\" >Are investigational antidepressants safe?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-33\" href=\"https:\/\/wniss.com\/en-gb\/clinical-developments-in-new-antidepressant-drugs-options-to\/#Source\" >Source<\/a><\/li><\/ul><\/nav><\/div>\n\n<div class=\"TyagGW_tableContainer\"><div tabindex=\"-1\" class=\"group TyagGW_tableWrapper flex flex-col-reverse w-fit\"><table class=\"w-fit min-w-(--thread-content-width)\"><thead><tr><th class=\"last:pe-10\">Topic<\/th><th class=\"last:pe-10\">Key Information<\/th><\/tr><\/thead><tbody><tr><td>Primary Focus<\/td><td>New antidepressant drugs<\/td><\/tr><tr><td>Best Candidates<\/td><td>Adults with major depressive disorder under medical supervision<\/td><\/tr><tr><td>Major Innovations<\/td><td>Glutamate modulators, neuroactive steroids, psychedelic-assisted research<\/td><\/tr><tr><td>Typical Benefits<\/td><td>Faster symptom relief, alternative mechanisms, improved remission rates<\/td><\/tr><tr><td>Limitations<\/td><td>Cost, availability, monitoring requirements, long-term research ongoing<\/td><\/tr><tr><td>Medical Oversight<\/td><td>Essential for diagnosis, treatment selection, and monitoring<\/td><\/tr><\/tbody><\/table><div class=\"relative h-0 self-end select-none\"><div class=\"absolute end-0 flex items-end\" style=\"height: 32.7969px;\"><span class=\"\"><button aria-label=\"\u0646\u0633\u062e \u0627\u0644\u062c\u062f\u0648\u0644\" class=\"hover:bg-token-bg-tertiary text-token-text-secondary relative z-10 my-1 rounded-sm p-1 transition-opacity group-[:not(:hover):not(:focus-within)]:pointer-events-none group-[:not(:hover):not(:focus-within)]:opacity-0\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"20\" height=\"20\" aria-hidden=\"true\" class=\"icon\"><use href=\"\/cdn\/assets\/sprites-core-2f140ca8.svg#ce3544\" fill=\"currentColor\"><\/use><\/svg><\/button><\/span><\/div><\/div><\/div><\/div>\n<p>Within the last decade, <strong>new antidepressant drugs<\/strong> have expanded treatment possibilities for people living with depression. While selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) remain common first-line treatments, researchers continue developing medications that work through different biological pathways.<\/p>\n<p>These innovations are especially important for individuals with treatment-resistant depression, where conventional medications may provide limited relief. Scientists are investigating faster-acting therapies, personalized medicine approaches, and medications with fewer unwanted side effects.<\/p>\n<p><strong>Suggested Internal Links<\/strong><\/p>\n<ul>\n<li>\n<p>Learn more about depression symptoms and treatment: <span class=\"decorated-link\">https:\/\/wniss.com\/en-gb\/depression\/<span aria-hidden=\"true\" class=\"ms-0.5 inline-block align-middle leading-none select-none\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"20\" height=\"20\" aria-hidden=\"true\" class=\"block h-[0.75em] w-[0.75em] stroke-current stroke-[0.75] select-none\"><use href=\"\/cdn\/assets\/sprites-core-2f140ca8.svg#304883\" fill=\"currentColor\"><\/use><\/svg><\/span><\/span><\/p>\n<\/li>\n<li>\n<p>Explore additional mental health resources: <span class=\"decorated-link\">https:\/\/wniss.com\/en-gb\/category\/depression\/<span aria-hidden=\"true\" class=\"ms-0.5 inline-block align-middle leading-none select-none\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"20\" height=\"20\" aria-hidden=\"true\" class=\"block h-[0.75em] w-[0.75em] stroke-current stroke-[0.75] select-none\"><use href=\"\/cdn\/assets\/sprites-core-2f140ca8.svg#304883\" fill=\"currentColor\"><\/use><\/svg><\/span><\/span><\/p>\n<\/li>\n<\/ul>\n<hr>\n<h2><span class=\"ez-toc-section\" id=\"Why_New_Antidepressant_Drugs_Are_Needed\"><\/span>Why New Antidepressant Drugs Are Needed<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Although traditional antidepressants help millions of people, they have several limitations.<\/p>\n<p>Common challenges include:<\/p>\n<ul>\n<li>\n<p>Delayed onset of action<\/p>\n<\/li>\n<li>\n<p>Partial symptom improvement<\/p>\n<\/li>\n<li>\n<p>Treatment resistance<\/p>\n<\/li>\n<li>\n<p>Sexual side effects<\/p>\n<\/li>\n<li>\n<p>Weight changes<\/p>\n<\/li>\n<li>\n<p>Sleep disturbances<\/p>\n<\/li>\n<li>\n<p>Medication discontinuation symptoms<\/p>\n<\/li>\n<\/ul>\n<p>Approximately one-third of patients do not achieve full remission after initial treatment. Consequently, researchers continue searching for medications with improved effectiveness and faster results.<\/p>\n<hr>\n<h2><span class=\"ez-toc-section\" id=\"How_Traditional_Antidepressants_Work\"><\/span>How Traditional Antidepressants Work<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Most conventional antidepressants increase neurotransmitters such as:<\/p>\n<ul>\n<li>\n<p>Serotonin<\/p>\n<\/li>\n<li>\n<p>Norepinephrine<\/p>\n<\/li>\n<li>\n<p>Dopamine (indirectly in some medications)<\/p>\n<\/li>\n<\/ul>\n<p>Medication classes include:<\/p>\n<h3><span class=\"ez-toc-section\" id=\"SSRIs\"><\/span>SSRIs<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Examples include:<\/p>\n<ul>\n<li>\n<p>Sertraline<\/p>\n<\/li>\n<li>\n<p>Escitalopram<\/p>\n<\/li>\n<li>\n<p>Fluoxetine<\/p>\n<\/li>\n<li>\n<p>Paroxetine<\/p>\n<\/li>\n<\/ul>\n<h3><span class=\"ez-toc-section\" id=\"SNRIs\"><\/span>SNRIs<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Examples include:<\/p>\n<ul>\n<li>\n<p>Venlafaxine<\/p>\n<\/li>\n<li>\n<p>Duloxetine<\/p>\n<\/li>\n<li>\n<p>Desvenlafaxine<\/p>\n<\/li>\n<\/ul>\n<h3><span class=\"ez-toc-section\" id=\"Atypical_Antidepressants\"><\/span>Atypical Antidepressants<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>These include medications like:<\/p>\n<ul>\n<li>\n<p>Bupropion<\/p>\n<\/li>\n<li>\n<p>Mirtazapine<\/p>\n<\/li>\n<li>\n<p>Vortioxetine<\/p>\n<\/li>\n<li>\n<p>Vilazodone<\/p>\n<\/li>\n<\/ul>\n<p>Although effective for many individuals, researchers recognized that depression involves more complex brain circuits than serotonin alone.<\/p>\n<hr>\n<h2><span class=\"ez-toc-section\" id=\"The_Shift_Toward_Novel_Mechanisms\"><\/span>The Shift Toward Novel Mechanisms<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Modern neuroscience suggests depression affects:<\/p>\n<ul>\n<li>\n<p>Neural plasticity<\/p>\n<\/li>\n<li>\n<p>Brain connectivity<\/p>\n<\/li>\n<li>\n<p>Stress hormone regulation<\/p>\n<\/li>\n<li>\n<p>Glutamate signaling<\/p>\n<\/li>\n<li>\n<p>GABA activity<\/p>\n<\/li>\n<li>\n<p>Neuroinflammation<\/p>\n<\/li>\n<\/ul>\n<p>As a result, <strong>new antidepressant drugs<\/strong> increasingly target these biological systems instead of relying solely on serotonin enhancement.<\/p>\n<hr>\n<h2><span class=\"ez-toc-section\" id=\"Glutamate-Based_Antidepressants\"><\/span>Glutamate-Based Antidepressants<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>One of the biggest breakthroughs involves glutamate, the brain&#8217;s primary excitatory neurotransmitter.<\/p>\n<p>Researchers discovered that modulating NMDA receptors can rapidly improve depressive symptoms.<\/p>\n<p>Potential advantages include:<\/p>\n<ul>\n<li>\n<p>Faster symptom improvement<\/p>\n<\/li>\n<li>\n<p>Improved emotional processing<\/p>\n<\/li>\n<li>\n<p>Enhanced brain plasticity<\/p>\n<\/li>\n<li>\n<p>Better outcomes for treatment-resistant depression<\/p>\n<\/li>\n<\/ul>\n<p>This represented one of the most significant advances in depression treatment in decades.<\/p>\n<hr>\n<h2><span class=\"ez-toc-section\" id=\"Esketamine_A_Rapid-Acting_Option\"><\/span>Esketamine: A Rapid-Acting Option<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Esketamine nasal spray became one of the first approved rapid-acting antidepressant therapies.<\/p>\n<p>Unlike traditional antidepressants, it may improve symptoms within hours or days rather than several weeks.<\/p>\n<p>Clinical use generally involves:<\/p>\n<ul>\n<li>\n<p>Certified treatment centers<\/p>\n<\/li>\n<li>\n<p>Medical observation after dosing<\/p>\n<\/li>\n<li>\n<p>Combination with an oral antidepressant<\/p>\n<\/li>\n<li>\n<p>Careful patient selection<\/p>\n<\/li>\n<\/ul>\n<p>Because of potential side effects, administration occurs under healthcare supervision.<\/p>\n<hr>\n<h2><span class=\"ez-toc-section\" id=\"Neuroactive_Steroids\"><\/span>Neuroactive Steroids<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Researchers also developed medications that influence GABA receptors.<\/p>\n<p>These compounds aim to restore healthy communication between brain cells while reducing depressive symptoms.<\/p>\n<p>Potential benefits include:<\/p>\n<ul>\n<li>\n<p>Rapid onset<\/p>\n<\/li>\n<li>\n<p>Different biological target<\/p>\n<\/li>\n<li>\n<p>Improved mood regulation<\/p>\n<\/li>\n<\/ul>\n<p>Some neuroactive steroids have shown encouraging clinical trial results, particularly for postpartum depression.<\/p>\n<hr>\n<h2><span class=\"ez-toc-section\" id=\"Psychedelic-Assisted_Research\"><\/span>Psychedelic-Assisted Research<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Clinical studies continue evaluating psychedelic compounds under carefully supervised medical settings.<\/p>\n<p>Research areas include:<\/p>\n<ul>\n<li>\n<p>Psilocybin-assisted therapy<\/p>\n<\/li>\n<li>\n<p>MDMA-assisted psychotherapy for related psychiatric conditions<\/p>\n<\/li>\n<li>\n<p>Novel psychedelic analogues<\/p>\n<\/li>\n<\/ul>\n<p>Although promising, these treatments remain highly regulated, and availability depends on local approvals and clinical guidelines.<\/p>\n<hr>\n<h2><span class=\"ez-toc-section\" id=\"Triple_Reuptake_Inhibitors\"><\/span>Triple Reuptake Inhibitors<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Researchers continue developing medications that simultaneously influence:<\/p>\n<ul>\n<li>\n<p>Serotonin<\/p>\n<\/li>\n<li>\n<p>Norepinephrine<\/p>\n<\/li>\n<li>\n<p>Dopamine<\/p>\n<\/li>\n<\/ul>\n<p>The goal is broader symptom improvement, especially for:<\/p>\n<ul>\n<li>\n<p>Low motivation<\/p>\n<\/li>\n<li>\n<p>Fatigue<\/p>\n<\/li>\n<li>\n<p>Cognitive dysfunction<\/p>\n<\/li>\n<li>\n<p>Reduced pleasure<\/p>\n<\/li>\n<\/ul>\n<p>Many candidates remain under clinical investigation.<\/p>\n<hr>\n<h2><span class=\"ez-toc-section\" id=\"Personalized_Medicine\"><\/span>Personalized Medicine<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Future depression treatment increasingly focuses on individualized care.<\/p>\n<p>Researchers study factors including:<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Genetics\"><\/span>Genetics<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Genetic testing may eventually help predict:<\/p>\n<ul>\n<li>\n<p>Medication response<\/p>\n<\/li>\n<li>\n<p>Side effect risk<\/p>\n<\/li>\n<li>\n<p>Drug metabolism<\/p>\n<\/li>\n<\/ul>\n<h3><span class=\"ez-toc-section\" id=\"Biomarkers\"><\/span>Biomarkers<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Potential biomarkers include:<\/p>\n<ul>\n<li>\n<p>Inflammatory markers<\/p>\n<\/li>\n<li>\n<p>Brain imaging<\/p>\n<\/li>\n<li>\n<p>Hormonal changes<\/p>\n<\/li>\n<li>\n<p>Protein signatures<\/p>\n<\/li>\n<\/ul>\n<p>Although promising, routine clinical use remains limited.<\/p>\n<hr>\n<h2><span class=\"ez-toc-section\" id=\"Artificial_Intelligence_in_Drug_Discovery\"><\/span>Artificial Intelligence in Drug Discovery<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Artificial intelligence is accelerating antidepressant development by:<\/p>\n<ul>\n<li>\n<p>Identifying drug candidates<\/p>\n<\/li>\n<li>\n<p>Predicting molecular interactions<\/p>\n<\/li>\n<li>\n<p>Optimizing clinical trial design<\/p>\n<\/li>\n<li>\n<p>Discovering new therapeutic targets<\/p>\n<\/li>\n<\/ul>\n<p>This technology may significantly reduce the time required to develop future medications.<\/p>\n<hr>\n<h2><span class=\"ez-toc-section\" id=\"Precision_Psychiatry\"><\/span>Precision Psychiatry<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Precision psychiatry combines multiple data sources, including:<\/p>\n<ul>\n<li>\n<p>Clinical history<\/p>\n<\/li>\n<li>\n<p>Genetics<\/p>\n<\/li>\n<li>\n<p>Lifestyle<\/p>\n<\/li>\n<li>\n<p>Digital health monitoring<\/p>\n<\/li>\n<li>\n<p>Biomarkers<\/p>\n<\/li>\n<\/ul>\n<p>The objective is selecting the most appropriate treatment earlier in the recovery process.<\/p>\n<hr>\n<h2><span class=\"ez-toc-section\" id=\"Faster_Symptom_Relief\"><\/span>Faster Symptom Relief<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>One major goal of <strong>new antidepressant drugs<\/strong> is reducing treatment delay.<\/p>\n<p>Potential clinical advantages include:<\/p>\n<ul>\n<li>\n<p>Lower suicide risk through earlier intervention<\/p>\n<\/li>\n<li>\n<p>Faster functional recovery<\/p>\n<\/li>\n<li>\n<p>Reduced hospitalization<\/p>\n<\/li>\n<li>\n<p>Improved treatment adherence<\/p>\n<\/li>\n<\/ul>\n<p>Rapid symptom improvement may substantially enhance quality of life for selected patients.<\/p>\n<hr>\n<h2><span class=\"ez-toc-section\" id=\"Addressing_Cognitive_Symptoms\"><\/span>Addressing Cognitive Symptoms<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Depression often affects:<\/p>\n<ul>\n<li>\n<p>Memory<\/p>\n<\/li>\n<li>\n<p>Concentration<\/p>\n<\/li>\n<li>\n<p>Decision-making<\/p>\n<\/li>\n<li>\n<p>Processing speed<\/p>\n<\/li>\n<\/ul>\n<p>New medications increasingly evaluate improvements in cognitive functioning alongside mood symptoms.<\/p>\n<hr>\n<h2><span class=\"ez-toc-section\" id=\"Improving_Emotional_Function\"><\/span>Improving Emotional Function<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Researchers now recognize that successful treatment involves more than reducing sadness.<\/p>\n<p>Modern clinical trials also measure improvements in:<\/p>\n<ul>\n<li>\n<p>Motivation<\/p>\n<\/li>\n<li>\n<p>Social functioning<\/p>\n<\/li>\n<li>\n<p>Daily productivity<\/p>\n<\/li>\n<li>\n<p>Emotional resilience<\/p>\n<\/li>\n<li>\n<p>Quality of life<\/p>\n<\/li>\n<\/ul>\n<hr>\n<h2><span class=\"ez-toc-section\" id=\"Reducing_Side_Effects\"><\/span>Reducing Side Effects<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>An important research priority involves minimizing:<\/p>\n<ul>\n<li>\n<p>Sexual dysfunction<\/p>\n<\/li>\n<li>\n<p>Weight gain<\/p>\n<\/li>\n<li>\n<p>Daytime fatigue<\/p>\n<\/li>\n<li>\n<p>Gastrointestinal symptoms<\/p>\n<\/li>\n<li>\n<p>Sleep disruption<\/p>\n<\/li>\n<\/ul>\n<p>Better tolerability may improve long-term medication adherence.<\/p>\n<hr>\n<h2><span class=\"ez-toc-section\" id=\"Safety_Considerations\"><\/span>Safety Considerations<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Even the newest medications require careful medical evaluation.<\/p>\n<p>Healthcare providers consider:<\/p>\n<ul>\n<li>\n<p>Current medications<\/p>\n<\/li>\n<li>\n<p>Medical history<\/p>\n<\/li>\n<li>\n<p>Pregnancy status<\/p>\n<\/li>\n<li>\n<p>Liver and kidney function<\/p>\n<\/li>\n<li>\n<p>Substance use<\/p>\n<\/li>\n<li>\n<p>Psychiatric history<\/p>\n<\/li>\n<\/ul>\n<p>Regular follow-up remains essential regardless of medication type.<\/p>\n<hr>\n<h2><span class=\"ez-toc-section\" id=\"Who_May_Benefit_Most\"><\/span>Who May Benefit Most?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Some patients who may discuss newer therapies with their clinician include those with:<\/p>\n<ul>\n<li>\n<p>Treatment-resistant depression<\/p>\n<\/li>\n<li>\n<p>Severe depressive episodes<\/p>\n<\/li>\n<li>\n<p>Significant functional impairment<\/p>\n<\/li>\n<li>\n<p>Recurrent depression<\/p>\n<\/li>\n<li>\n<p>Poor tolerance of standard medications<\/p>\n<\/li>\n<\/ul>\n<p>Treatment decisions should always be individualized.<\/p>\n<hr>\n<h2><span class=\"ez-toc-section\" id=\"Ongoing_Clinical_Trials\"><\/span>Ongoing Clinical Trials<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Researchers continue studying medications targeting:<\/p>\n<ul>\n<li>\n<p>Neuroplasticity<\/p>\n<\/li>\n<li>\n<p>Brain inflammation<\/p>\n<\/li>\n<li>\n<p>Orexin pathways<\/p>\n<\/li>\n<li>\n<p>Opioid receptor modulation<\/p>\n<\/li>\n<li>\n<p>Circadian rhythm regulation<\/p>\n<\/li>\n<li>\n<p>Stress hormone systems<\/p>\n<\/li>\n<\/ul>\n<p>Many investigational compounds remain in Phase II and Phase III clinical trials.<\/p>\n<hr>\n<h2><span class=\"ez-toc-section\" id=\"Future_Directions\"><\/span>Future Directions<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The future of depression treatment is likely to include:<\/p>\n<ul>\n<li>\n<p>Precision medicine<\/p>\n<\/li>\n<li>\n<p>Biomarker-guided prescribing<\/p>\n<\/li>\n<li>\n<p>Faster-acting medications<\/p>\n<\/li>\n<li>\n<p>Combination therapies<\/p>\n<\/li>\n<li>\n<p>Digital treatment monitoring<\/p>\n<\/li>\n<li>\n<p>Novel brain-targeted medications<\/p>\n<\/li>\n<\/ul>\n<p>Rather than relying on one treatment approach, clinicians increasingly expect individualized treatment plans tailored to each patient&#8217;s biological and psychological profile.<\/p>\n<hr>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span>Frequently Asked Questions<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Are_new_antidepressant_drugs_better_than_older_medications\"><\/span>Are new antidepressant drugs better than older medications?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Not necessarily. Traditional antidepressants remain effective for many people. Newer drugs primarily offer additional options, especially for patients who do not respond adequately to conventional treatments.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_new_antidepressant_works_the_fastest\"><\/span>Which new antidepressant works the fastest?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Rapid-acting therapies such as esketamine can improve symptoms within hours or days for some patients, whereas many traditional antidepressants require several weeks.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Are_these_medications_available_everywhere\"><\/span>Are these medications available everywhere?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Availability varies by country, healthcare system, regulatory approval, and clinical setting.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Can_newer_antidepressants_replace_psychotherapy\"><\/span>Can newer antidepressants replace psychotherapy?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>No. Many people benefit most from combining medication with evidence-based psychotherapy, lifestyle changes, and ongoing medical care.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Are_investigational_antidepressants_safe\"><\/span>Are investigational antidepressants safe?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Before approval, investigational medications undergo multiple phases of clinical testing to evaluate safety and effectiveness. Even after approval, continued monitoring helps identify long-term benefits and risks.<\/p>\n<hr>\n<h2><span class=\"ez-toc-section\" id=\"Source\"><\/span>Source<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><span class=\"decorated-link\">https:\/\/en.wikipedia.org\/wiki\/Depression_(mood)<span aria-hidden=\"true\" class=\"ms-0.5 inline-block align-middle leading-none select-none\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"20\" height=\"20\" aria-hidden=\"true\" class=\"block h-[0.75em] w-[0.75em] stroke-current stroke-[0.75] select-none\"><use href=\"\/cdn\/assets\/sprites-core-2f140ca8.svg#304883\" fill=\"currentColor\"><\/use><\/svg><\/span><\/span><\/p>\n<hr>\n<p><strong>Medical Disclaimer<\/strong><\/p>\n<p>The materials and information provided in this article are for educational and informational purposes only and are not a substitute for consultation with a qualified physician or licensed healthcare provider. Do not rely on this information to diagnose or treat any medical condition. Always consult your healthcare provider before starting any new treatment or making changes to your diet or medications.<\/p><\/div>\n<figure class=\"wch-inserted-image\"><img decoding=\"async\" width=\"1024\" height=\"683\" src=\"https:\/\/wniss.com\/wp-content\/uploads\/2026\/09\/clinical-developments-in-new-antidepressant-drugs-options-to-2-lfli09-1024x683.webp\" alt=\"Clinical Developments in New Antidepressant Drugs Options To - Clinical Developments in New Antidepressant\" loading=\"lazy\" class=\"wp-image-6219\" title=\"\" srcset=\"https:\/\/wniss.com\/wp-content\/uploads\/2026\/09\/clinical-developments-in-new-antidepressant-drugs-options-to-2-lfli09-1024x683.webp 1024w, https:\/\/wniss.com\/wp-content\/uploads\/2026\/09\/clinical-developments-in-new-antidepressant-drugs-options-to-2-lfli09-300x200.webp 300w, https:\/\/wniss.com\/wp-content\/uploads\/2026\/09\/clinical-developments-in-new-antidepressant-drugs-options-to-2-lfli09-150x100.webp 150w, https:\/\/wniss.com\/wp-content\/uploads\/2026\/09\/clinical-developments-in-new-antidepressant-drugs-options-to-2-lfli09-100x67.webp 100w, https:\/\/wniss.com\/wp-content\/uploads\/2026\/09\/clinical-developments-in-new-antidepressant-drugs-options-to-2-lfli09-200x133.webp 200w, https:\/\/wniss.com\/wp-content\/uploads\/2026\/09\/clinical-developments-in-new-antidepressant-drugs-options-to-2-lfli09-250x167.webp 250w, https:\/\/wniss.com\/wp-content\/uploads\/2026\/09\/clinical-developments-in-new-antidepressant-drugs-options-to-2-lfli09-350x233.webp 350w, https:\/\/wniss.com\/wp-content\/uploads\/2026\/09\/clinical-developments-in-new-antidepressant-drugs-options-to-2-lfli09-400x267.webp 400w, https:\/\/wniss.com\/wp-content\/uploads\/2026\/09\/clinical-developments-in-new-antidepressant-drugs-options-to-2-lfli09-500x333.webp 500w, https:\/\/wniss.com\/wp-content\/uploads\/2026\/09\/clinical-developments-in-new-antidepressant-drugs-options-to-2-lfli09-600x400.webp 600w, https:\/\/wniss.com\/wp-content\/uploads\/2026\/09\/clinical-developments-in-new-antidepressant-drugs-options-to-2-lfli09.webp 1200w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure><figure class=\"wch-inserted-image\"><img decoding=\"async\" width=\"1024\" height=\"683\" src=\"https:\/\/wniss.com\/wp-content\/uploads\/2026\/09\/clinical-developments-in-new-antidepressant-drugs-options-to-3-LwIsr8-1024x683.webp\" alt=\"Clinical Developments in New Antidepressant Drugs Options To - Clinical Developments in New Antidepressant\" loading=\"lazy\" class=\"wp-image-6220\" title=\"\" srcset=\"https:\/\/wniss.com\/wp-content\/uploads\/2026\/09\/clinical-developments-in-new-antidepressant-drugs-options-to-3-LwIsr8-1024x683.webp 1024w, https:\/\/wniss.com\/wp-content\/uploads\/2026\/09\/clinical-developments-in-new-antidepressant-drugs-options-to-3-LwIsr8-300x200.webp 300w, https:\/\/wniss.com\/wp-content\/uploads\/2026\/09\/clinical-developments-in-new-antidepressant-drugs-options-to-3-LwIsr8-150x100.webp 150w, https:\/\/wniss.com\/wp-content\/uploads\/2026\/09\/clinical-developments-in-new-antidepressant-drugs-options-to-3-LwIsr8-100x67.webp 100w, https:\/\/wniss.com\/wp-content\/uploads\/2026\/09\/clinical-developments-in-new-antidepressant-drugs-options-to-3-LwIsr8-200x133.webp 200w, https:\/\/wniss.com\/wp-content\/uploads\/2026\/09\/clinical-developments-in-new-antidepressant-drugs-options-to-3-LwIsr8-250x167.webp 250w, https:\/\/wniss.com\/wp-content\/uploads\/2026\/09\/clinical-developments-in-new-antidepressant-drugs-options-to-3-LwIsr8-350x233.webp 350w, https:\/\/wniss.com\/wp-content\/uploads\/2026\/09\/clinical-developments-in-new-antidepressant-drugs-options-to-3-LwIsr8-400x267.webp 400w, https:\/\/wniss.com\/wp-content\/uploads\/2026\/09\/clinical-developments-in-new-antidepressant-drugs-options-to-3-LwIsr8-500x333.webp 500w, https:\/\/wniss.com\/wp-content\/uploads\/2026\/09\/clinical-developments-in-new-antidepressant-drugs-options-to-3-LwIsr8-600x400.webp 600w, https:\/\/wniss.com\/wp-content\/uploads\/2026\/09\/clinical-developments-in-new-antidepressant-drugs-options-to-3-LwIsr8.webp 1200w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>","protected":false},"excerpt":{"rendered":"<p>Clinical Developments in New Antidepressant Drugs: Emerging Treatment Options Quick Answer New antidepressant drugs are transforming depression treatment by targeting brain pathways [&hellip;]<\/p>\n","protected":false},"author":11,"featured_media":6218,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[730],"tags":[],"class_list":["post-4777","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-depression"],"acf":[],"_links":{"self":[{"href":"https:\/\/wniss.com\/en-gb\/wp-json\/wp\/v2\/posts\/4777","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wniss.com\/en-gb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wniss.com\/en-gb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wniss.com\/en-gb\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/wniss.com\/en-gb\/wp-json\/wp\/v2\/comments?post=4777"}],"version-history":[{"count":2,"href":"https:\/\/wniss.com\/en-gb\/wp-json\/wp\/v2\/posts\/4777\/revisions"}],"predecessor-version":[{"id":6221,"href":"https:\/\/wniss.com\/en-gb\/wp-json\/wp\/v2\/posts\/4777\/revisions\/6221"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wniss.com\/en-gb\/wp-json\/wp\/v2\/media\/6218"}],"wp:attachment":[{"href":"https:\/\/wniss.com\/en-gb\/wp-json\/wp\/v2\/media?parent=4777"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wniss.com\/en-gb\/wp-json\/wp\/v2\/categories?post=4777"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wniss.com\/en-gb\/wp-json\/wp\/v2\/tags?post=4777"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}